EU seeks advice on long-term effects of GMO crops

	Tweet

The European Commission wants to know how genetically modified (GMO) crops might affect human and animal health in the longer term, eight years after the EU first allowed biotech crops, a document showed on Tuesday.

On its Web site, the Commission’s environment unit has advertised for interested parties to study the “potential cumulative long-term effects” of individual groups of GMO crops, and identify where more research is required.

Only a handful of GMO crops may be grown commercially on EU territory, mostly maize types. These crop approvals were issued in 1997 and 1998, before the bloc began a six-year moratorium on new GMO authorisations that ended May 2004.

"This task should be prioritised to take account of the types of GM plants released within the Community at the present time and those predicted in the near future,” the notice said.

Last week the Commission held its first debate on GMO policy in more than a year, vowing to press ahead with authorising more gene-altered crops and foods even if EU governments could not break years of deadlock over the issue.

While new approvals are trickling in, they have so far related to imported GMOs for use in food, animal feed and industrial processing. No GMO crop has been won EU approval for planting since 1998.

“This study is partly about finding out where the gaps are. There are still some things about GMOs that we don’t know...but we know more about them now than we did at the time (in 1997 and 1998),” a Commission official told Reuters.

But green groups said the offer demonstrates how little EU research has been conducted on the long-term effects of GMOs on human and animal health, as well as on the environment.

“We’ve a huge debate (on GMOs) for eight years and in that time there have been no long-term studies,” said Adrian Bebb, GMO campaigner at environment group Friends of the Earth.

“Consumers have been exposed to this, animals on farms have been exposed to eating huge amounts of GM feed with no long-term study,” he said. “And they (Commission) are now admitting they haven’t done the research.”

A budget of 50,000 euros, excluding tax, has been allocated for the study. The deadline for bids is May 17. 

RELATED STORIES:
S. Sudan disease kills 31; treatment impeded   Woman gives birth to mutant baby in Malaysia   Student doctors call for ban on drug company bribes   Some antibiotic resistance threat in hospitals could yield to hand washing   Obesity rates for U.S. immigrants vary   Parents win high court battle to keep their baby alive   Vatican backs adult stem cell research   Health stories by experts more credible than blogs   Romanian mental hospitals “inhuman”, says Amnesty   Media Ignores Health Consequences of Drinking and Driving Among Young Celebrities   City Doctors still work for too long   Having a Higher Purpose in Life Reduces Risk of Death Among Older Adults

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]